Ophthalmology – Wilson’s Disease

What the Disorder Represents

Wilson disease (WD) is an autosomal recessive disorder of copper metabolism caused by pathogenic variants in ATP7B.

Defective hepatic copper handling causes:

• Impaired biliary copper excretion
• Progressive hepatic copper accumulation
• Release of excess copper into the circulation
• Deposition in the brain, cornea, kidneys, and other tissues

The classic ophthalmic sign is:

Kayser-Fleischer (KF) ring — copper deposition in Descemet membrane at the peripheral cornea.

Another characteristic ocular manifestation is:

Sunflower cataract.

The Genetic Defect

Wilson disease is caused by pathogenic variants in:

ATP7B on chromosome 13q14.3.

ATP7B normally participates in:

• Transport of excess copper into bile
• Incorporation of copper into apoceruloplasmin

Loss of ATP7B function therefore leads to:

Hepatic copper retention and reduced circulating ceruloplasmin.

How the Disorder Is Inherited

Inheritance is:

Autosomal recessive.

For two carrier parents, each pregnancy carries approximately:

• 25% chance of an affected child
• 50% chance of a carrier
• 25% chance of an unaffected noncarrier

Siblings of an affected patient should generally undergo:

Targeted screening.

Important Modern Correction About Genetic Testing

Older references described molecular testing as useful mainly after identifying a familial mutation.

This is outdated.

ATP7B sequencing and deletion/duplication analysis are now routinely available and can:

• Confirm the diagnosis
• Clarify equivocal biochemical testing
• Screen relatives
• Support reproductive counseling

A negative molecular test does not completely exclude WD when clinical suspicion remains high.

Why Copper Accumulates

Dietary copper is absorbed from the gastrointestinal tract and delivered to the liver.

Normally, the liver:

• Incorporates copper into ceruloplasmin
• Excretes excess copper into bile

In WD:

Biliary copper excretion fails.

Copper therefore accumulates within hepatocytes and eventually causes:

• Oxidative injury
• Mitochondrial dysfunction
• Hepatitis
• Fibrosis
• Cirrhosis

How Extrahepatic Disease Develops

As hepatocyte storage capacity is exceeded, toxic copper enters the circulation and deposits in:

• Basal ganglia
• Cornea
• Kidneys
• Other tissues

This produces the neurologic, psychiatric, ocular, and renal manifestations of WD.

Who Typically Presents With Wilson Disease

Presentation varies by age.

Children and Adolescents

More commonly present with:

Hepatic disease

such as:

• Asymptomatic transaminase elevation
• Chronic hepatitis
• Cirrhosis
• Acute liver failure

Adolescents and Young Adults

More commonly develop:

• Neurologic symptoms
• Psychiatric symptoms
• Mixed hepatic-neurologic disease

However, presentation can occur over a much wider age range.

Hepatic Manifestations

Liver disease may include:

• Elevated aminotransferases
• Fatty liver
• Chronic hepatitis
• Cirrhosis
• Portal hypertension
• Jaundice
• Ascites
• Acute liver failure

WD should be considered in:

Unexplained liver disease in a child, adolescent, or young adult.

A Particularly Important Hepatic Presentation

Wilson-related acute liver failure may be accompanied by:

• Coombs-negative hemolytic anemia
• Jaundice
• Coagulopathy
• Renal dysfunction

This is a medical emergency and may require:

Urgent liver transplantation.

Neurologic Manifestations

Neurologic disease commonly includes:

• Tremor
• Dysarthria
• Dystonia
• Parkinsonism
• Ataxia
• Chorea
• Drooling
• Gait disturbance

A characteristic proximal upper-extremity tremor may produce a:

“Wing-beating” appearance.

Psychiatric Manifestations

Psychiatric or behavioral symptoms may precede obvious neurologic disease.

These include:

• Personality change
• Depression
• Irritability
• Anxiety
• Reduced school or work performance
• Psychosis in selected patients

A young patient with unexplained psychiatric symptoms plus:

• Liver abnormalities
• Movement disorder
• KF rings

should prompt evaluation for WD.

Ocular Motor Abnormalities

Neurologic WD may affect eye movements.

Reported abnormalities include:

• Impaired smooth pursuit
• Saccadic abnormalities
• Vertical gaze abnormalities in some patients

These are secondary to CNS involvement rather than primary ocular disease.

Kayser-Fleischer Rings

The hallmark ocular sign is:

Copper deposition within Descemet membrane of the peripheral cornea.

The ring may appear:

• Golden-brown
• Green-brown
• Gray-brown

It is most easily detected by:

Slit-lamp examination.

How Kayser-Fleischer Rings Develop

Copper deposition often begins at:

• Superior cornea
• Inferior cornea

and subsequently progresses circumferentially.

Early incomplete arcs can therefore be missed without careful slit-lamp examination.

Where the Copper Is Located

KF rings occur primarily in:

Descemet membrane near the limbus.

They should not be confused with:

• Arcus
• Pigment on the anterior corneal surface
• Fleischer ring of keratoconus

How Common Are KF Rings?

They are present in:

Most patients with neurologic Wilson disease

but are less frequent in patients presenting only with hepatic disease.

Therefore:

Absence of a KF ring does not exclude Wilson disease.

Are KF Rings Specific?

They are highly characteristic in the appropriate clinical setting but are not completely specific.

Similar peripheral corneal copper deposition can occasionally occur with:

Chronic cholestatic liver disease.

Clinical and biochemical context therefore matters.

Effect of Treatment on KF Rings

With effective copper-lowering therapy:

• KF rings may fade
• Their density may decrease
• They can disappear over time

Persistence does not necessarily indicate treatment failure if systemic copper control is otherwise satisfactory.

Sunflower Cataract

Another classic ocular finding is the:

Sunflower cataract.

It results from copper deposition in the:

• Anterior lens capsule
• Sometimes posterior capsule

The appearance consists of:

• Central disc-like opacity
• Radiating petal-like spokes

Visual Effect of Sunflower Cataract

Despite its dramatic appearance, a sunflower cataract often causes:

Relatively little visual impairment.

It may partially or completely regress with successful copper chelation.

Other Ophthalmic Findings

Less common or nonspecific findings include:

• Reduced vision secondary to neurologic disease
• Ocular motility abnormalities
• Rare optic nerve abnormalities

The major ophthalmic diagnostic findings remain:

KF rings and sunflower cataract.

How the Diagnosis Is Established

No single laboratory test establishes WD in every patient.

Diagnosis relies on a combination of:

• Clinical findings
• Serum ceruloplasmin
• 24-hour urinary copper
• Slit-lamp examination for KF rings
• Hepatic copper measurement when necessary
• ATP7B genetic testing

A structured approach such as the:

Leipzig scoring system

is commonly used when the diagnosis is uncertain.

The Leipzig Diagnostic Approach

The Leipzig score assigns weight to findings such as:

• KF rings
• Neurologic manifestations
• Serum ceruloplasmin
• Coombs-negative hemolysis
• Hepatic copper
• Urinary copper
• ATP7B pathogenic variants

A sufficiently high score strongly supports:

Wilson disease.

Serum Ceruloplasmin

Serum ceruloplasmin is often:

Low

in WD.

A markedly reduced value strongly supports the diagnosis, but:

Ceruloplasmin alone is neither sensitive nor specific enough to diagnose WD.

Why Ceruloplasmin Can Mislead

Low ceruloplasmin can also occur with:

• Severe liver failure
• Protein-losing enteropathy
• Nephrotic syndrome
• Malnutrition
• Heterozygous ATP7B carrier state

Conversely, ceruloplasmin may be normal or elevated because it is an:

Acute-phase reactant.

Levels may increase with:

• Inflammation
• Pregnancy
• Estrogen exposure

Thus normal ceruloplasmin does not exclude WD.

Serum Copper

Total serum copper may paradoxically be:

Low

because much circulating copper is normally carried by ceruloplasmin.

However, the biologically toxic:

Non-ceruloplasmin-bound copper

is increased in untreated WD.

Limitation of Calculated “Free Copper”

Traditional calculated non-ceruloplasmin copper can be inaccurate because:

• Ceruloplasmin assays vary
• Total serum copper assays vary
• The calculation compounds assay error

It should not be interpreted in isolation.

More direct assays of exchangeable copper are emerging in specialist centers.

24-Hour Urinary Copper

Untreated symptomatic patients usually have increased urinary copper excretion.

A level of approximately:

>100 µg/24 hours in symptomatic adults

strongly supports WD, although thresholds differ by age and clinical setting.

Moderately elevated values may occur in other liver diseases.

Penicillamine Challenge Testing

Older protocols used a:

D-penicillamine challenge test

particularly in children.

This approach now has a much more limited role because of:

• Variable diagnostic performance
• Better genetic testing
• Improved biochemical assessment

It should not be considered a routine modern diagnostic requirement.

Hepatic Copper Quantification

When diagnosis remains uncertain, liver biopsy may be used to measure:

Hepatic copper concentration.

A concentration:

>250 µg/g dry weight

strongly supports Wilson disease.

However, sampling variability can occur, particularly in:

• Advanced cirrhosis

and elevated hepatic copper can also occur in:

• Severe cholestatic disorders

So results require clinical interpretation.

Liver Biopsy Is Not Always Required

Modern diagnosis often can be established without biopsy when there is a convincing combination of:

• KF rings
• Neurologic disease
• Low ceruloplasmin
• Elevated urinary copper
• ATP7B pathogenic variants

Biopsy is most useful when:

The diagnosis remains ambiguous.

Histopathologic Liver Findings

Liver histology may show:

• Steatosis
• Chronic hepatitis
• Fibrosis
• Cirrhosis

These are not specific.

Routine histochemical copper staining has limited sensitivity because copper distribution can be:

Patchy.

Quantitative hepatic copper is more useful.

Brain MRI

MRI is preferred over CT for neurologic WD.

Commonly affected structures include:

• Putamen
• Caudate
• Globus pallidus
• Thalamus
• Brainstem

MRI may show:

• T2/FLAIR signal abnormalities
• Atrophy in advanced disease
• Other basal ganglia changes

The “Face of the Giant Panda” Sign

A classic but uncommon MRI sign is the:

“Face of the giant panda”

appearance in the midbrain.

It is associated with Wilson disease but is:

Not required and not sufficiently sensitive to use as a diagnostic test.

Renal Manifestations

Copper toxicity can produce proximal tubular dysfunction leading to:

• Fanconi syndrome
• Aminoaciduria
• Phosphaturia
• Glycosuria despite normal serum glucose
• Nephrolithiasis

Renal disease is less prominent than hepatic or neurologic involvement.

Hematologic Manifestations

WD can cause:

Coombs-negative intravascular hemolysis

especially during acute liver failure.

Sudden release of hepatic copper damages erythrocytes.

Skeletal and Other Manifestations

Patients may develop:

• Arthralgia
• Osteopenia
• Premature osteoarthritis
• Rare cardiac abnormalities

These manifestations are less diagnostically prominent.

Important Diagnostic Alternatives

Depending on presentation, consider:

Hepatic Disease

• Viral hepatitis
• Autoimmune hepatitis
• Drug-induced liver injury
• Metabolic liver disease
• Alpha-1 antitrypsin deficiency

Neurologic Disease

• Young-onset Parkinsonism
• Huntington disease
• Dystonia syndromes
• Mitochondrial disease

Corneal Ring

• Chronic cholestatic copper deposition
• Other peripheral corneal pigmentation disorders

Screening Family Members

First-degree relatives, especially siblings, should be assessed because early WD may be:

Completely asymptomatic.

Evaluation may include:

• ATP7B genetic testing
• Ceruloplasmin
• Liver tests
• Urinary copper
• Ophthalmic examination

when appropriate.

Early diagnosis can prevent irreversible organ damage.

The Core Treatment Principle

Treatment must:

Reduce toxic copper and prevent its reaccumulation for life.

Therapy is lifelong, including in asymptomatic patients once the diagnosis is established.

Stopping therapy can cause:

• Hepatic decompensation
• Neurologic deterioration
• Acute liver failure

Copper Chelation

Chelators bind copper and increase urinary excretion.

The major agents are:

• D-penicillamine
• Trientine

Both can effectively reduce body copper stores.

D-Penicillamine

D-penicillamine was historically the standard first-line chelator.

Potential adverse effects include:

• Neurologic worsening after initiation
• Bone marrow suppression
• Proteinuria
• Nephrotoxicity
• Autoimmune reactions
• Skin abnormalities

Pyridoxine supplementation is generally given because penicillamine interferes with vitamin B6 metabolism.

Trientine

Trientine is now widely used as an alternative and in many settings is favored because of a more favorable adverse-effect profile than penicillamine.

It can also occasionally cause:

• Iron deficiency
• Cytopenia
• Neurologic worsening

Treatment selection is individualized with hepatology or a Wilson disease specialist.

Important Modern Correction About Zinc

Older sources sometimes recommended administering zinc together with trientine.

In practice:

Chelators and zinc should generally be separated in time

because they can interfere with one another’s absorption and action.

They are not simply taken simultaneously as a routine combination.

Zinc Therapy

Zinc induces intestinal:

Metallothionein

which binds dietary copper within enterocytes and reduces systemic absorption.

Zinc is particularly useful for:

• Presymptomatic disease
• Maintenance therapy
• Selected patients who cannot tolerate chelators

Its role in symptomatic disease depends on severity and specialist strategy.

Zinc Is Slower Than Chelation

Because zinc primarily blocks new copper absorption rather than rapidly removing stored copper, it acts more slowly.

Therefore severe:

• Hepatic disease
• Neurologic disease

often requires more active decoppering therapy.

Risk of Neurologic Worsening

A clinically important complication of chelation is:

Initial worsening of neurologic symptoms.

This is thought to result from mobilization of tissue copper and redistribution.

It can occur with:

• Penicillamine
• Trientine

though historically it has been particularly associated with penicillamine.

Slow dose escalation may be used in neurologic presentations.

Liver Transplantation

Liver transplantation is potentially curative for the hepatic metabolic defect.

It is indicated particularly for:

• Acute liver failure from Wilson disease
• Decompensated cirrhosis refractory to medical therapy

Transplantation restores normal hepatic ATP7B function and copper handling.

Treatment During Pregnancy

Women with WD should generally:

Continue anti-copper therapy during pregnancy

because stopping treatment can cause severe maternal deterioration.

Drug choice and dose require:

• Hepatology
• Obstetric
• Genetic counseling input

Doses may be adjusted during pregnancy and around delivery.

Dietary Copper Restriction

Dietary restriction is most important during the early treatment phase.

Foods particularly high in copper include:

• Liver
• Shellfish
• Nuts
• Chocolate
• Mushrooms

Diet alone is:

Not sufficient treatment.

Drinking Water and Copper Exposure

Patients should consider the copper content of:

• Well water
• Old copper plumbing
• Copper cookware

when environmental exposure may be substantial.

Routine extreme dietary restriction is not necessary once effective medical therapy is established.

Monitoring Treatment

Long-term monitoring may include:

• Liver enzymes
• INR
• CBC
• Creatinine
• Urinalysis
• 24-hour urinary copper
• Clinical neurologic assessment
• Treatment adherence

Monitoring strategy differs according to whether the patient receives:

• Chelator therapy
• Zinc

Why Monitoring Urinary Copper Matters

During chelation, urinary copper helps assess:

• Treatment effect
• Adherence
• Possible overtreatment

Inappropriately low values may indicate:

• Nonadherence
• Excessive depletion

depending on treatment context.

Watching for Copper Deficiency

Excessive treatment can cause:

Iatrogenic copper deficiency.

Possible manifestations include:

• Anemia
• Neutropenia
• Myelopathy
• Peripheral neuropathy

Copper-lowering therapy therefore requires careful monitoring rather than simply maximizing drug dose.

Ophthalmic Follow-Up

Slit-lamp examination can document:

• KF ring density
• Regression with treatment
• Sunflower cataract

However, systemic copper control should be assessed primarily through:

Clinical and biochemical monitoring, not by the corneal ring alone.

Do Kayser-Fleischer Rings Require Ocular Treatment?

No.

KF rings are:

A diagnostic marker, not an ocular lesion requiring laser or surgery.

They fade as systemic copper burden decreases.

Does Sunflower Cataract Require Surgery?

Usually not.

Because sunflower cataracts may:

• Cause little visual impairment
• Regress with copper-lowering treatment

cataract surgery is rarely required solely for this finding.

Genetic Counseling

Because WD is autosomal recessive, counseling should address:

• Sibling testing
• Carrier status
• Reproductive implications
• Partner testing in selected circumstances

Identifying presymptomatic affected relatives is especially valuable because:

Early treatment can prevent disease manifestations.

Expected Long-Term Course

Without treatment, Wilson disease can cause:

• Progressive cirrhosis
• Severe neurologic disability
• Acute liver failure
• Death

With early diagnosis and lifelong effective treatment:

Life expectancy can approach normal.

Neurologic Prognosis

Neurologic recovery may take:

• Months
• Years

and may be incomplete.

Persistent problems can include:

• Dysarthria
• Dystonia
• Tremor

Early treatment before extensive CNS injury offers the best prognosis.

Ocular Prognosis

Ocular findings usually improve with systemic treatment.

• KF rings often fade
• Sunflower cataract may regress
• Neither usually causes major permanent visual loss

Thus the eye is particularly valuable as a:

Diagnostic window into systemic copper toxicity.

High-Yield Takeaways

• Wilson disease is an autosomal recessive copper-transport disorder caused by ATP7B pathogenic variants on chromosome 13q14.3.
• ATP7B normally facilitates biliary copper excretion and incorporation of copper into ceruloplasmin.
• Copper first accumulates in the liver, then damages the brain, cornea, kidneys, and other tissues.
• Children more commonly present with hepatic disease, whereas adolescents and young adults may develop neurologic or psychiatric disease.
• The classic ophthalmic sign is the Kayser-Fleischer ring, representing copper deposition in peripheral Descemet membrane.
• KF deposition usually begins superiorly and inferiorly before becoming circumferential.
• Most neurologic WD patients have KF rings, but their absence does not exclude hepatic Wilson disease.
• KF rings are highly characteristic but can rarely occur with other severe cholestatic disorders.
• Sunflower cataract is another characteristic copper-deposition sign and often causes little visual disability.
• Diagnosis uses a combination of ceruloplasmin, 24-hour urinary copper, KF rings, hepatic copper, and ATP7B genetic testing rather than any single test.
• The Leipzig score is useful when the diagnosis is uncertain.
• Low ceruloplasmin supports WD but is neither fully sensitive nor specific; normal levels do not exclude disease.
• Symptomatic untreated patients commonly have 24-hour urinary copper >100 µg/day.
• Hepatic copper >250 µg/g dry weight strongly supports WD, although biopsy is no longer required in every patient.
• Modern ATP7B genetic testing is widely available and is not restricted to family screening.
• Neurologic MRI commonly involves the basal ganglia; the “giant panda” sign is classic but uncommon.
• Treatment is lifelong and includes copper chelation with trientine or D-penicillamine and/or zinc according to disease stage.
• Chelation can initially worsen neurologic symptoms, particularly in patients with neurologic presentation.
• Zinc reduces intestinal copper absorption and is especially useful in presymptomatic and maintenance therapy.
• Chelators and zinc should generally be separated in time, rather than routinely taken together.
• Wilson-related acute liver failure or refractory decompensated cirrhosis requires urgent consideration of liver transplantation.
• Anti-copper treatment generally needs to continue during pregnancy under specialist supervision.
• Excessive therapy can produce copper deficiency with cytopenias or neurologic injury, so biochemical monitoring is essential.
• KF rings and sunflower cataracts themselves usually require no direct ophthalmic treatment.
• With early recognition and sustained therapy, systemic and ocular prognosis can be excellent; untreated Wilson disease can be fatal.

High-Yield Takeaways